{Reference Type}: Case Reports
{Title}: Pemetrexed-Induced Interstitial Pneumonitis: A Case Study and Literature Review.
{Author}: Waters MJ;Sukumaran S;Karapetis CS;
{Journal}: World J Oncol
{Volume}: 5
{Issue}: 5
{Year}: Dec 2014
暂无{DOI}: 10.14740/wjon845w
{Abstract}: Pemetrexed is a new-generation antifolate drug, now widely used in patients with non-small cell lung cancer (NSCLC). We report a case of pemetrexed-induced interstitial pneumonitis, and review the literature of eight previously reported cases. As pemetrexed is now a widely used chemotherapeutic agent, it is important to be aware of rare adverse events related to its administration.